Search results
9 lip 2024 · The materials can be downloaded for free in PDF format, bookmarked or shared with loved ones. You can also find our educational resources in Spanish within Komen en Español. Learn about Interpreter (Translator) Services.
NCCN Guidelines for Patients ® help people with cancer talk with their doctors about the best treatment options for their disease. NCCN translates these patient resources into multiple languages so that they may be accessed by patients and care providers around the world.
Introducción. La mastectomía profiláctica contralateral (MPC) ha sido evaluada como estrategia para la reducción del riesgo de cáncer de mama contralateral (CMC) en pacientes con un cáncer de mama esporádico (es decir, sin mutaciones en los principales genes asociados al cáncer de mama hereditario, y sin una fuerte historia familiar) 1.
25 paź 2024 · Topics covered include: the breast and breast cancer, risk factors, diagnosis and staging, treatment, survivorship, integrative and complementary therapy, support, specific populations and resources. After Early Breast Cancer- Signs and Symptoms of Metastatic Breast Cancer View PDF
20 lip 2005 · Contralateral breast cancer (CBC) is the most common second primary cancer in patients diagnosed with breast cancer. 1 Patients with a history of breast cancer have an increased risk of developing a second primary breast cancer (PBC), with an annual risk of 0.5% to 1% or a cumulative lifetime risk of 2% to 15%. 2 Because breast cancer is the ...
Breast cancer can be found by mammogram, by a woman feeling a lump or by a doctor’s exam. To find breast cancer, it is important to: Do monthly self breast exams. Have a yearly exam by your doctor if you are over 40. These are done less often for younger women. Have a mammogram each year after age.
RESUMEN. Se ha observado una tendencia en los últimos años a un incremento de la mastectomía profiláctica contralateral en pacientes con diagnóstico de cáncer de mama unilateral, argumentada como cirugía reductora de riesgo y de prevención del desarrollo futuro de cáncer de mama en la mama sana.